NOT-TR-21-012: Notice of NCATS Withdrawal from Participation in PAR-20-243, "Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01

Notice of NCATS Withdrawal from Participation in PAR-20-243, "Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)"

Notice Number:

NOT-TR-21-012

Key Dates

Release Date:

December, 15, 2020

Related Announcements

PAR-20-243 - Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)

Issued by

National Center for Advancing Translational Sciences (NCATS)

Purpose

Effective immediately, the National Center for Advancing Translational Sciences (NCATS) withdraws its participation on PAR-20-243 – “Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)". Submissions intended for NCATS which are received after today’s date will be withdrawn.

Applicants interested in submitting research projects consistent with the mission of the NCATS CTSA Program to address the COVID-19 pandemic are encouraged to contact a Program Officer in the Clinical and Translational Science Award Program to discuss their proposed work and identify an appropriate Funding Opportunity Announcement (FOA). For example, consideration might be given to COVID-19 focused projects through the CTSA Program Collaborative Innovation Awards opportunities.

Inquiries

Please direct all inquiries to:

Audie Atienza, Ph.D.
National Center for Advancing Translational Sciences (NCATS)

Email:[email protected]